Registration Strip Icon for smarter Negocie de forma mais inteligente, não mais difícil: Libere seu potencial com nosso conjunto de ferramentas e discussões ao vivo.

CFMS

Conformis (CFMS)

Conformis Inc
De:
Ordenação:
 Apresentando as notícias mais relevantes sobre:NASDAQ:CFMS
DataHoraFonteTítuloCódigoCompanhia
15/09/202310:56Edgar (US Regulatory)Form 15-12G - Securities registration termination [Section 12(g)]NASDAQ:CFMSConformis Inc
05/09/202309:18GlobeNewswire Inc.restor3d Completes Acquisition of ConformisNASDAQ:CFMSConformis Inc
05/09/202309:14Edgar (US Regulatory)Form 25-NSE - Notification filed by national security exchange to report the removal from listing and registration of matured, redeemed or retired securitiesNASDAQ:CFMSConformis Inc
05/09/202307:13Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:CFMSConformis Inc
05/09/202307:08Edgar (US Regulatory)Form S-8 POS - Securities to be offered to employees in employee benefit plans, post-effective amendmentsNASDAQ:CFMSConformis Inc
05/09/202307:01Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:CFMSConformis Inc
24/08/202318:04Edgar (US Regulatory)Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) materialNASDAQ:CFMSConformis Inc
23/08/202309:00GlobeNewswire Inc.Independent Proxy Advisory Firms ISS and Glass Lewis Recommend Conformis Stockholders Vote “FOR” the Pending Merger with restor3dNASDAQ:CFMSConformis Inc
21/08/202317:10GlobeNewswire Inc.Independent Proxy Advisory Firm ISS Recommends Conformis Stockholders Vote “FOR” the Pending Merger with restor3dNASDAQ:CFMSConformis Inc
02/08/202318:22Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:CFMSConformis Inc
02/08/202318:15GlobeNewswire Inc.Conformis Reports Second Quarter 2023 Financial ResultsNASDAQ:CFMSConformis Inc
24/07/202309:00Edgar (US Regulatory)Form DEFM14A - Definitive proxy statement relating to merger or acquisitionNASDAQ:CFMSConformis Inc
14/07/202317:28Edgar (US Regulatory)Form PREM14A - Preliminary proxy statements relating to merger or acquisitionNASDAQ:CFMSConformis Inc
26/06/202318:27Edgar (US Regulatory)Additional Proxy Soliciting Materials (definitive) (defa14a)NASDAQ:CFMSConformis Inc
22/06/202323:05GlobeNewswire Inc.Conformis Announces Definitive Agreement to be Acquired by restor3d for a Purchase Price of $2.27 Per Share in CashNASDAQ:CFMSConformis Inc
11/05/202318:14Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:CFMSConformis Inc
10/05/202317:56Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:CFMSConformis Inc
08/05/202309:21Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:CFMSConformis Inc
08/05/202309:05GlobeNewswire Inc.Conformis Reports First Quarter 2023 Financial ResultsNASDAQ:CFMSConformis Inc
13/04/202317:30GlobeNewswire Inc.Conformis, Inc. to Announce Financial Results for Its First Quarter on May 8, 2023NASDAQ:CFMSConformis Inc
24/03/202317:02Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:CFMSConformis Inc
21/03/202308:00GlobeNewswire Inc.Conformis Launches Patient Awareness Campaign to Highlight the Benefits of Personalized Knee Replacement ProceduresNASDAQ:CFMSConformis Inc
01/03/202318:19Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:CFMSConformis Inc
01/03/202318:05GlobeNewswire Inc.Conformis, Inc. Reports Fourth Quarter and Year End 2022 Financial ResultsNASDAQ:CFMSConformis Inc
21/02/202318:15GlobeNewswire Inc.Conformis, Inc. to Participate in Upcoming Investor ConferencesNASDAQ:CFMSConformis Inc
15/02/202318:15GlobeNewswire Inc.Conformis, Inc., Bodycad Laboratories, Inc. and Bodycad USA Corp. Announce Settlement of Patent LitigationNASDAQ:CFMSConformis Inc
10/02/202309:00GlobeNewswire Inc.Conformis Provides Business Update and Reports Preliminary Results for Fourth Quarter and Full-Year 2022NASDAQ:CFMSConformis Inc
09/02/202319:29Edgar (US Regulatory)Statement of Ownership (sc 13g)NASDAQ:CFMSConformis Inc
23/01/202318:30GlobeNewswire Inc.Conformis, Inc. to Announce Financial Results for Its Fourth Quarter and Full-Year 2022NASDAQ:CFMSConformis Inc
30/11/202218:30GlobeNewswire Inc.Conformis, Inc. Regains Compliance with Nasdaq’s Minimum Bid Price RuleNASDAQ:CFMSConformis Inc
 Apresentando as notícias mais relevantes sobre:NASDAQ:CFMS